CyGenica has announced that it has raised USD $1.4 million in a seed fund investment round, led by global venture capital investor SOSV. The funding round will accelerate validation of CyGenica’s proprietary technology which enables safe, targeted, and affordable intercellular drug delivery.
CyGenica’s disruptive technology addresses the problem of delivering large-molecule therapeutics into living cells without damaging them or triggering an adverse immune response.
- Read more about Indo-Irish Biotech Startup CyGenica Secures Funding from SOSV to Accelerate Cancer and Rare Genetic Disease Therapy
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/indo-irish-biotech-startup-cygenica-secures-funding-from-sosv-to-accelerate-cancer-and-rare-genetic-disease-therapy
No comments:
Post a Comment